Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06033365 · ClinicalTrials.gov registry record · NA
Beginning Early and Assertive Treatment for Methamphetamine Use Disorder
A NA study, sponsored by Denver Health and Hospital Authority.
- Completed
- Registry status
- NA
- Development phase
- 192
- Enrollment target
NCT06033365: Completed NA study, sponsored by Denver Health and Hospital Authority.
NCT06033365 is a NA study that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 192 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06033365, a NA study, has completed, sponsored by Denver Health and Hospital Authority.
- COMPLETED
- Registry status
- NA
- Development phase
- 192 participants
- Enrollment target
Study Summary
The overall goal of the study is to evaluate the effectiveness of a secondary prevention strategy implemented at a systems-level to prevent stimulant related overdoses.
Primary Outcome
Treatment entry as defined as attendance at an outpatient addiction treatment appointment within 30 days of BEAT Meth discharge
Interventions
- BEHAVIORAL care navigation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2023-04-11 |
| Est. Completion | 2025-09-29 |
| Phase | NA |
What the finished NCT06033365 record still lists
NCT06033365 is an interventional study that assigns participants to a tested intervention. The registered 192 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which care navigation is the first listed.
NCT06033365 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06033365 about?
NCT06033365 is a clinical study titled "Beginning Early and Assertive Treatment for Methamphetamine Use Disorder". The overall goal of the study is to evaluate the effectiveness of a secondary prevention strategy implemented at a systems-level to prevent stimulant related overdoses.
What is the current status of trial NCT06033365?
This trial is currently completed. It is a NA study. The enrollment target is 192 participants. The study started on 2023-04-11. Estimated completion is 2025-09-29.
What interventions are being tested in trial NCT06033365?
The interventions under investigation include: care navigation (BEHAVIORAL).
Who is sponsoring clinical trial NCT06033365?
This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06033365's enrollment target sits among peer trials
192 570th of 2000 higher than 1,427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492972 · 192 participants · Phase 3
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- NCT01973881 · 192 participants
Quantitative MRI for Myelofibrosis
- NCT02535702 · 192 participants · NA
Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction
- NCT03622359 · 192 participants · NA
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI